Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Dyadic International, Inc. (NASDAQ:DYAI) shares are trading higher on Thursday, after the company announced its platform is to be used by the Israeli Research Institution to develop a treatment for the COVID-19.
The company participated in the 32nd annual ROTH conference, which was held virtually.
During the conference, Dyadic management presented coronavirus opportunities and new research partners, its feasibility study with University of Oslo on influenza vaccine and four novel C1 cell lines.
Dyadic is a biotechnology company focused on the patented and proprietary C1 expression system to help bring biologic vaccines and drugs to market faster.
Dyadic's was trading up 35% at $3.47 per share at time of publication. The stock has a 52-week high of $8 and a 52-week low of $2.51.
Related Links:
Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna
Volunteers Begin Testing Moderna Coronavirus Vaccine
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!